+
Site Tour
Heart Failure

STAGES OF HEART FAILURE1,2

CLASS I
No symptoms or limitations to physical activity.

CLASS II
Slight limitations of physical activity. Comfortable at rest; ordinary physical activity results in feeling tired and shortness of breath.

CLASS III
Significant limitations of physical activity. Less than ordinary activity causes results in feeling tired and shortness of breath.

CLASS IV
Unable to carry on any physical activity without discomfort. Tired and shortness of breath even at rest.


*INTERMACS Registry = Interagency Registry for Mechanically Assisted Circulatory Support

INTERMACS PROFILES

  • NYHA classification does not offer adequate description to allow optimal selection of patients for current options of medical and device therapies, HTx and MCS
  • NYHA III and IV Patients who may be considered for MCS can now be classified using 7 INTERMACS profiles.

MECHANICAL CIRCULATORY SUPPORT (MCS)

Indications for short- and long-term MCS should be based on the INTERMACS profiles4

aThis algorithm can be applied to all patients with advanced HF defined according to the HFA-ESC criteria,5 with exception of hypertrophic cardiomyopathy (HCM), cardiac arrest (CA), arrhythmic storm, adult congenital heart disease, refractory angina.

bRecurrent hospitalization, progressive end-organ failure, refractory congestion, inability to perform cardiopulmonary exercise test or peak oxygen consumption <12 mL/min/kg or <50% of expected value.6

Colour code for classes of recommendation: Green for Class of recommendation I and Yellow for Class of recommendation IIa.

INTERAGENCY REGISTRY FOR MECHANICALLY ASSISTED CIRCULATORY SUPPORT PROFILE DESCRIPTIONS OF PATIENTS WITH ADVANCED HEART FAILURE4

ProfileTime frame for intervention
Profile 1. Critical cardiogenic shock
Patient with life-threatening hypotension despite rapidly escalating inotropic support, critical organ hypoperfusion, often confirmed by worsening acidosis and/or lactate levels.“Crash and burn.”
Definitive intervention needed within hours.
Profile 2. Progressive decline 
Patient with declining function despite i.v. inotropic support, may be manifest by worsening renal function, nutritional depletion, inability to restore volume balance. “Sliding on inotropes.” Also describes declining status in patients unable to tolerate inotropic therapy.
Definitive intervention needed within few days.
Profile 3. Stable on inotrope or inotrope-dependent 
Patient with stable blood pressure, organfunction, nutrition, and symptoms on continuous i.v. inotropic support (or a temporary circulatory support device or both) but demonstrating repeated failure to wean from support due to recurrent symptomatic hypotension or renal dysfunction. “Dependent stability.” 

Definitive intervention elective over a period of weeks to few months.

Profile 4. Frequent Flyer 
Patient can be stabilized close to normal volume status but experiences daily symptoms of congestion at rest or during activities of daily living. Doses of diuretics generally fluctuate at very high levels. More intensive management and surveillance strategies should be considered, which may in some cases reveal poor compliance that would compro-mise outcomes with any therapy. Some patients may shuttle between 4 and 5.
Definitive intervention elective over a period of weeks to few months.
Profile 5. Housebound 
Comfortable at rest and with activities of daily living but unable to engage in any other activity, living predominantly within the house. Patients are comfortable at rest without congestive symptoms, but may have underlying refractory elevated volume status, often with renal dysfunction. If underlying nutritional status and organ function are marginal, patients may be more at risk than INTERMACS 4, and require definitive intervention.
Variable urgency, depends upon maintenance of nutrition, organ function, and activity.
Profile 6. Exertion limited
Patient without evidence of fluid overload, comfortable at rest and with activities of daily living and minor activities outside the home but fatigues after the first few minutes of any meaningful activity. Attribution to cardiac limitation requires careful measurement of peak oxygen consumption, in some cases with haemodynamic monitoring, to confirm severity of cardiac impairment. “Walking wounded.”
Variable, depends upon maintenance of nutrition, organ function, and activity level.
Profile 7. Advanced NYHA class III symptoms
Patient without current or recent episodes of unstable fluid balance, living comfortably with meaningful activity limited to mild physical exertion.
Heart transplantation or MCS may not be currently indicated.
Modifiers for profilesPossible profiles that can be modified
Temporary MCS can modify profile only in hospitalized patients. They include IABP, ECMO, TandemHeart, LVAD, Impella.1, 2, 3
Arrhythmia can modify any profile. They include recurrent ventricular tachyarrhythmias that have recently contributed substantially to clinical compromise, frequent ICD shocks or requirement for external defibrillation, usually more than twice weekly.1-7
Frequent episodes of HF decompensation characterize patients requiring frequent emergency visits or hospitalizations for diuretics, ultrafiltration, or temporary i.v. vasoactive therapy. Frequent episodes may be considered as at least two emergency visits/admissions in the past 3 months or three in the past 6 months.3 if at home, 4, 5, 6. Rarely for profile 7.


BTB=bridge to bridge; BTC=bridge to candidacy; BTD=bridge to decision; BTR=bridge to recovery; BTT=bridge to transplantation; CA=cardiac amyloidosis; DT=destination therapy; ECMO=extracorporeal membrane oxygenation; ESC=European Society of Cardiology; HCM=hypertrophic cardiomyopathy; HF=heart failure; HFA=Heart Failure Association; HT or HTx=heart transplantation; IABP=intra-aortic balloon pump; ICD=implantable cardioverter-defibrillator; INTERMACS=Interagency Registry for Mechanically Assisted Circulatory Support; i.v.=intravenous; LVAD=left ventricular assist device; LVAD-BTC=left ventricular assist device - bridge to candidacy; LVAD-DT=left ventricular assist device - destination therapy; MCS=mechanical circulatory support; NYHA=New York Heart Association.

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV


HUB

References
  1. Jessup M, Brozena S. Heart Failure. N Engl J Med. 2003;348(20):2007–2018. doi.org/10.1056/NEJMra021498.
  2. www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure. Accessed July 2023.
  3.  Teuteberg JJ, Cleveland JC, Cowger J, et al. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The changing landscape of devices and indications. Ann Thorac Surg. 2020;109(3):649–60. doi.org/10.1016/j.athoracsur.2019.12.005.
  4. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi.org/10.1093/eurheartj/ehab368.
  5. Eisman AS, Shah RV, Dhakal BP, et al. Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure. Circ Heart Fail. 2018;11(5):e004750. doi.org/10.1161/CIRCHEARTFAILURE.117.004750.
  6. Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35(1):1–23. doi.org/10.1016/j.healun.2015.10.023.
  7. Stevenson LW, Pagani FD, Young JB, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28(6):535–541. doi.org/10.1016/j.healun.2009.02.015.

© Abbott 2023. All rights reserved. 9-EH-5-14578-01 10-2023

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline